Dopamine Agonists in Clinical Research for New Tardive Dyskinesia Treatments

2015 ◽  
pp. 97-110 ◽  
Author(s):  
J. Gerlach ◽  
D. E. Casey
Keyword(s):  
Tardive Dyskinesia ◽  
Clinical Research ◽  
Dopamine Agonists

scholarly journals Tardive Dyskinesia and Akathasia: A Dopamine System Theory Clinical Review

2019 ◽  
Vol 4 (1) ◽  
Keyword(s):  
System Theory ◽  
Basal Ganglia ◽  
Tardive Dyskinesia ◽  
Dopamine Receptors ◽  
Clinical Review ◽  
Dopamine Agonists ◽  
First Generation ◽  
Second Generation ◽  
Dopamine System

Long term use of first generation anti-psychotics (FGAs) have been theorized in the formation of motion disorders Tardive Dyskinesia and Akathasia and due to the breakdown in the extra pyramidal system (EPS) located in the Basal Ganglia [1]. The second generation anti-psychotics (SGAs) were sourced to be the “treatment” of TD by blocking dopamine receptors with dopamine agonists of the D2-D5 receptors while also being seen as the genesis of AK. However, the blocking of the receptors in both motion disorders is a theory known as the dopamine blockage theory, despite the intermingle of other neurotransmitters such as Serotonin and Norepinephrine [2]

On the Use of Dopamine Agonists in Tardive Dyskinesia

1978 ◽  
Vol 135 (1) ◽  
pp. 132-a-133 ◽  
Author(s):  
T. R.E. BARNES ◽  
T. KIDGER ◽  
P. J. TAYLOR
Keyword(s):  
Tardive Dyskinesia ◽  
Dopamine Agonists

Another look at behavioral sciences in dentistry: perspectives on collaborative clinical research

1984 ◽  
Vol 48 (8) ◽  
pp. 448-452
Author(s):  
LA Tedesco ◽  
JE Albino ◽  
WM Feagans ◽  
RS Mackenzie
Keyword(s):  
Clinical Research ◽  
Behavioral Sciences
Sign in / Sign up

Export Citation Format

Share Document